UMMS Affiliation

Department of Pediatrics; Program in Molecular Medicine

Publication Date


Document Type



Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Disease Transmission, Vertical; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lymphocyte Activation; RNA, Viral; Reverse Transcriptase Inhibitors; T-Lymphocytes, Cytotoxic; Viral Load; Virus Replication


Life Sciences | Medicine and Health Sciences


Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long-term suppression of viral replication.


J Virol. 2000 Aug;74(15):6984-91.

Journal/Book/Conference Title

Journal of virology

Related Resources

Link to Article in PubMed

PubMed ID




To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.